Show simple item record

dc.contributor.authorMiddlebrook, Earl A.
dc.contributor.authorRomero, Alicia T.
dc.contributor.authorBett, Bernard
dc.contributor.authorNthiwa, Daniel M.
dc.contributor.authorOyola, Samuel O.
dc.contributor.authorFair, Jeanne M.
dc.contributor.authorBartlow, Andrew W.
dc.date.accessioned2022-01-18T07:55:24Z
dc.date.available2022-01-18T07:55:24Z
dc.date.issued2002-01
dc.identifier.citationZoonoses Public Health. 2022;00:1–20.en_US
dc.identifier.uriDOI: 10.1111/zph.12905
dc.identifier.urihttp://repository.embuni.ac.ke/handle/embuni/3910
dc.description.abstractZoonotic diseases, such as brucellosis, Q fever and Rift Valley fever (RVF) caused by Brucella spp., Coxiella burnetii and RVF virus, respectively, can have devastating effects on human, livestock, and wildlife health and cause economic hardship due to morbidity and mortality in livestock. Coinfection with multiple pathogens can lead to more severe disease outcomes and altered transmission dynamics. These three pathogens can alter host immune responses likely leading to increased morbidity, mortality and pathogen transmission during coinfection. Developing countries, such as those commonly afflicted by outbreaks of brucellosis, Q fever and RVF, have high disease burden and thus common coinfections. A literature survey provided information on case reports and studies investigating coinfections involving the three focal diseases. Fifty five studies were collected demonstrating coinfections of Brucella spp., C. burnetii or RVFV with 50 different pathogens, of which 64% were zoonotic. While the literature search criteria involved ‘coinfection’, only 24/55 studies showed coinfections with direct pathogen detection methods (microbiology, PCR and antigen test), while the rest only reported detection of antibodies against multiple pathogens, which only indicate a history of co- exposure, not concurrent infection. These studies lack the ability to test whether coinfection leads to changes in morbidity, mortality or transmission dynamics. We describe considerations and methods for identifying ongoing coinfections to address this critical blind spot in disease risk management.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectBrucellosisen_US
dc.subjectco- exposureen_US
dc.subjectdiagnosticsen_US
dc.subjectespecially dangerous pathogensen_US
dc.subjectQ feveren_US
dc.subjectRift Valley feveren_US
dc.subjectserologyen_US
dc.subjectzoonotic diseaseen_US
dc.titleIdentification and distribution of pathogens coinfecting with Brucella spp., Coxiella burnetii and Rift Valley fever virus in humans, livestock and wildlifeen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record